TRADING UPDATES: Staffline and Creo Medical report higher earnings
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 246.00p on 28-01-2026 at 17:00:06 |
|---|---|
| Change | -14.00p -5.38% |
| Buy | 265.00p |
| Sell | 245.00p |
| Last Trade: | Sell 2,631.00 at 246.00p |
| Day's Volume: | 36,103 |
| Last Close: | 246.00p |
| Open: | 260.00p |
| ISIN: | GB0032164732 |
| Day's Range | 246.00p - 260.00p |
| 52wk Range: | 180.00p - 306.00p |
| Market Capitalisation: | £99.47m |
| VWAP: | 260.49465p |
| Shares in Issue: | 40.44m |
Sector: Closed End Investments
Listed In: FTSE NSX
Jpmorgan Emea (JEMA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,631 | 246.00p | Uncrossing Trade |
16:35:25 - 28-Jan-26 |
| Buy* | 2,417 | 257.40p | Ordinary |
14:24:59 - 28-Jan-26 |
| Unknown* | 12,778 | 264.649p | Ordinary |
14:22:56 - 28-Jan-26 |
| Buy* | 1,481 | 256.90p | Ordinary |
14:07:32 - 28-Jan-26 |
| Buy* | 1,170 | 256.90p | Ordinary |
13:13:33 - 28-Jan-26 |
| Buy* | 1,170 | 256.90p | Ordinary |
13:02:34 - 28-Jan-26 |
| Buy* | 1,948 | 256.9138p | Ordinary |
12:37:51 - 28-Jan-26 |
| Buy* | 125 | 256.9238p | Ordinary |
12:21:10 - 28-Jan-26 |
| Buy* | 39 | 256.90p | Ordinary |
10:50:16 - 28-Jan-26 |
| Buy* | 677 | 256.90p | Ordinary |
10:42:53 - 28-Jan-26 |
Jpmorgan Emea (JEMA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Jan 2026 10:36 am | RNS | Net Asset Value(s) |
| 26th Jan 2026 10:52 am | RNS | Net Asset Value(s) |
| 23rd Jan 2026 10:36 am | RNS | Net Asset Value(s) |
| 22nd Jan 2026 11:11 am | RNS | Net Asset Value(s) |
| 21st Jan 2026 10:42 am | RNS | Net Asset Value(s) |
| 20th Jan 2026 2:08 pm | RNS | Russian Court Cases Update |
| 20th Jan 2026 10:59 am | RNS | Net Asset Value(s) |
| 19th Jan 2026 10:55 am | RNS | Net Asset Value(s) |
| 16th Jan 2026 11:04 am | RNS | Net Asset Value(s) |
| 15th Jan 2026 10:54 am | RNS | Net Asset Value(s) |